The Clinical Trial for Evaluation of Efficacy and Safety of rhEGF (Recombinant Human Epidermal Growth Factor) in Diabetic Foot Ulcer Patients With Uncontrolled Diabetes Mellitus.
Phase of Trial: Phase III
Latest Information Update: 03 Sep 2014
At a glance
- Drugs Nepidermin (Primary)
- Indications Diabetic foot ulcer
- Focus Therapeutic Use
- Sponsors Daewoong Pharmaceutical
- 03 Sep 2014 Results published in a Daewoong Pharmaceutical media release.
- 01 Aug 2014 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 12 Jul 2012 Planned patient number is 176 according to ClinicalTrials.gov.